button bars forest bayes pooled summary circles
 
deaths (OS)

mRCC - L1 - PDL1 positive metastatic/advanced RCC (mRCC) - 1st line (L1) mRCC - L1 - PDL1 positive

versus sunitinib
atezolizumab alone vs. sunitinib 1 -
atezolizumab plus bevacizumab vs. sunitinib 2 certainty unassessable-15%
avelumab plus axitinib vs. sunitinib 1 certainty unassessable-29%

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons